Literature DB >> 26255230

Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? A prospective cohort study.

Anees B Chagpar1, Meghan Butler2, Brigid K Killelea2, Nina R Horowitz2, Karen Stavris2, Donald R Lannin2.   

Abstract

BACKGROUND: Standard two-dimensional (2D) specimen radiography may guide intraoperative re-excision of margins in patients undergoing breast conserving surgery. We sought to determine the impact of three-dimensional (3D) specimen imaging in further reducing positive margin rates.
METHODS: A prospective study of 100 patients in which both 2D and 3D specimen radiographies were performed. The impact of orthogonal view on intraoperative surgical management and final margins was assessed.
RESULTS: Ten patients had no residual tumor; therefore, 90 patients formed the cohort of interest. Of them, 21 patients (23.3%) had ductal carcinoma in situ; 18 (20.0%) had invasive cancer; and 51 (56.7%) had both. Median tumor size was 1.7 cm (range, .2 to 8.1 cm). On the basis of 2D imaging, surgeons stated they would take more tissue in 26 patients (28.9%). Three-dimensional imaging changed management in 4 patients (6.3%). One of these patients would have had positive margins if the intraoperative resection done on the basis of the 3D imaging would have been omitted.
CONCLUSIONS: Three-dimensional specimen imaging results in further intraoperative re-excision in 6.3% of patients and may reduce re-excision rates in 2.2%.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast conservation; Margins; Specimen radiography; Surgery

Mesh:

Year:  2015        PMID: 26255230     DOI: 10.1016/j.amjsurg.2015.05.018

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

Review 1.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

Review 2.  Review of methods for intraoperative margin detection for breast conserving surgery.

Authors:  Benjamin W Maloney; David M McClatchy; Brian W Pogue; Keith D Paulsen; Wendy A Wells; Richard J Barth
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

3.  Optoacoustic characterization of breast conserving surgery specimens - A pilot study.

Authors:  Ghayathri Balasundaram; Yonggeng Goh; Mohesh Moothanchery; Amalina Attia; Hann Qian Lim; Neal C Burton; Yi Qiu; Thomas Choudary Putti; Ching Wan Chan; Mikael Hartmann; Swee Tian Quek; Malini Olivo
Journal:  Photoacoustics       Date:  2020-04-27

4.  Tumor-to-Gland Volume Ratio versus Tumor-to-Breast Ratio as Measured on CBBCT: Possible Predictors of Breast-Conserving Surgery.

Authors:  Jiawei Li; Guobin Zhong; Keqiong Wang; Wei Kang; Wei Wei
Journal:  Cancer Manag Res       Date:  2021-06-03       Impact factor: 3.989

5.  Optical scatter imaging of resected breast tumor structures matches the patterns of micro-computed tomography.

Authors:  Samuel S Streeter; Benjamin W Maloney; Rebecca A Zuurbier; Wendy A Wells; Richard J Barth; Keith D Paulsen; Brian W Pogue
Journal:  Phys Med Biol       Date:  2021-06-01       Impact factor: 4.174

6.  Indications and methods of intraoperative specimen radiography in breast-conserving surgery.

Authors:  Ji Young Kim; Yong Sik Jung; Se Hwan Han; Ji Hyun Sung; Min Hee Hur
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

7.  Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?

Authors:  Benedikt Schaefgen; Annika Funk; H-P Sinn; Thomas Bruckner; Christina Gomez; Aba Harcos; Anne Stieber; Annabelle Haller; Juliane Nees; Riku Togawa; André Pfob; André Hennigs; Johanna Hederer; Fabian Riedel; Sarah Fastner; Christof Sohn; Jörg Heil; Michael Golatta
Journal:  Breast Cancer Res Treat       Date:  2021-12-08       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.